EEUU aprob la primera pldora oral GLP-1 contra la obesidad La compaa, que espera lanzarla en EEUU a principios de enero de 2026 , present el tratamiento en la segunda mitad de 2025 en la Agencia Europea de Medicamentos (EMA) y otras autoridades reguladoras
REM Sleep: Pinealon + Glycine This is the most striking personal finding Huberman has shared about any peptide
I love this program and working with a team that are equally passionate, allowing me to continue to learn and grow
The abdomen is the recommended primary site, with the thigh and upper arm acting as acceptable secondary options
doi:10.1016/j.cmet.2020.03.004 Fanelli S, Francioso A, Cavallaro RA, dErme M, Putignano P, Miraglia N, et al